Celgene

This sponsor has funded 9 studies across 18 countries.

PAS funded by this sponsor.
EU PAS ID Status RMP requirement Title Protocol uploaded Results uploaded
7020 Finalised Not included in RMP No No
7023 Finalised EU RMP category 3 No No
7252 Ongoing EU RMP category 1 No No
7412 Finalised EU RMP category 1 No Yes
10153 Ongoing EU RMP category 1 No No
22604 Ongoing EU RMP category 1 No No
23366 Ongoing EU RMP category 3 No No
25626 Ongoing Not included in RMP No No
42016 Finalised EU RMP category 3 Yes No

PAS by Risk Management Plan (RMP) requirement

Celgene

The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.

Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.